Evaluating Use Of Innovative Technology In Home Health Care

November 11, 1997

University Park, Pa.- Diabetics in the Philadelphia area will be able to provide their blood sugar levels, pulse measurement, and temperature from home to the home health care nurses in their offices with the help of an innovative technology called Telehealth. A new, 24-month Penn State research project will evaluate the use of the technology as a supplement to on-going home health visits for people with diabetes.

Nationally, diabetes accounts for almost 15 percent of the nation's health care costs and affects 8.4 million people in the United States; in the Philadelphia metropolitan area, more than 200,000 people have diabetes.

The home health research project is funded in part by a grant for $603,610 from the Telecommunications and Information Infrastructure Assistance Program (TIIAP) of the National Telecommunications and Information Administration (NTIA), U.S. Department of Commerce. It will be led by Kathryn Dansky, Ph.D., assistant professor of health policy and administration in Penn State's College of Health and Human Development.

The University will partner with The Visiting Nurse Association of Greater Philadelphia for the evaluation. While there is increasing use of telecommunications technology in health care, it has been slow to move into home care, the fastest growing sector of the health care industry, according to Dr. Dansky. The Telehealth technology will allow the Philadelphia Visiting Nurse Association to engage in interactive video, voice and data communications with 200 to 250 of their clients using patient stations which will be placed in the home for a period of sixty days.

The Telehealth system captures and transmits vital medical data while providing remote visual and aural interactive assessment of the patient. The nurse station will allow for direct communication with the patient and will display vital sign readings. Nurses can transmit videos or teach patients about self care through the system. The system will be used in addition to actual home visits; researchers will then compare outcomes for Telehealth patients and traditional home health patients.

The co-investigator on the Telehealth project is Dennis Shea, associate professor of health policy and administration, who will evaluate the cost-effectiveness of the technology. Paul Hallacher, director of program development at Penn State'sResearch and Technology Transfer Organization, will manage a workshop on technology transfer as part of the project to help other health care organizations acquire and use similar technology. The project continues through September 1999.

The grant is part of $20.9 million in federal matching grants awarded by the Department of Commerce at the end of September to bring the benefits of technology to Americans living in rural and underserved inner city areas through the Telecommunications and Information Infrastructure Assistance Program (TIIAP). The federal funds will be matched locally.

**hhd**

EDITOR: Dr. Dansky is at (814) 863-2902 or kxd9@psu.edu by email.

Contact:
Jean Erstling
(814) 863-4325
jbe4@psu.edu

Penn State

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.